LinkedIn video ad examples

Transgenic mouse models for academic research and rare disease studies. Some research questions require a precise genetic model. At the Genome Engineering Facility, the IN-MOL-CELL infrastructure at the International Institute of Molecular and Cell Biology in Warsaw supports researchers in developing genetically modified and transgenic mouse models using CRISPR/Cas9 technology. The facility combines molecular biology, genetic engineering and embryology expertise. Its services include consulting on custom projects, designing mutagenesis strategies, microinjections into oocytes and zygotes, genotyping, mouse breeding, initial phenotyping, sperm and embryo cryopreservation, and mouse line rederivation. These models support studies ranging from basic gene function to rare disease mechanisms and the search for potential therapeutic strategies. Learn more on the main IN-MOL-CELL website: https://lnkd.in/dwuHh_3Q IN-MOL-CELL Infrastructure is funded by the European Union - NextGenerationEU under the National Recovery and Resilience Plan. IN-MOL-CELL Infrastructure is also funded by the European Union under Horizon Europe, Project 101059801 - RACE, and by the RACE-PRIME project carried out within the IRAP programme of the Foundation for Polish Science, co-financed by the European Union under the European Funds for Smart Economy 2021-2027. #IIMCB #INMOLCELL #GenomeEngineering #CRISPRCas9 #RareDiseaseResearch #MouseModels #ResearchInfrastructure #MolecularBiology #ResearchInfrastructure #KorzyściDlaCiebie, #NextGenerationEU, #FunduszeUE

Quer uma experiência assistencial real ainda na graduação? O Hospital Alemão Oswaldo Cruz abre vagas para Enfermagem.

Desenvolva competências técnicas e humanas na linha de frente do cuidado. Inscrições abertas de 08/06 a 05/07 para Enfermagem.

Embrace the Case. - 43-year-old female - Liver metastasis from breast cancer, Segment V - Unresectable, multiple prior chemotherapy regimens Treated with Embrace® HES. - 28% diameter reduction at 30 days - 45% diameter reduction at 90 days - No revascularization - No local tumor progression Conclusion: Transarterial embolization with Embrace® HES in managing unresectable liver metastases from breast cancer. Sustained tumor control with no contrast uptake or local progression through 90 days, and partial response by mRECIST criteria. View the full case: https://lnkd.in/grYuttAt #EmbraceHES #Instylla #InterventionalRadiology #Embolization #IR #InterventionalOncology #LiverMetastasis

As societies around the world age, the question is not simply how long we live, but how well we live. Speaking at FutureHealth․Now 2026, Dr Min-Han Tan, Founding CEO and Medical Director of Lucence, shared why prevention should be the starting point for maximising both healthspan and quality of life, highlighting IHH HEALTHCARE SINGAPORE's Healthspan initiative as a step in that direction. #IHHHealthcare #CareForGood #FutureHealthNow

We caught up with Daniel Ting, Joseph Sung and Jennie Kung at FutureHealth․Now 2026 to hear their perspectives on AI, connected care and what it takes to keep patients at the centre of every decision. Watch the conversation. #IHHHealthcare #CareForGood #FutureHealthNow

What’s top of mind for Medical Affairs leaders at #FiercePharmaWeek? For Lori Klein, PharmD, Inizio Ignite, one conversation has stood out: the growing role of Medical Affairs in enterprise decision-making. From strengthening strategic skills and business acumen to contributing more meaningfully to decisions across the organization, hear Lori’s perspective on what she’s been hearing at Fierce Pharma Week. 👇 #FPW2026 #MedicalAffairs #Pharma #IntelligentCommercialization #FiercePharma

Embrace the Case. - 69-year-old male - Advanced HCC, Segment V liver, 4.7 cm with residual 1.5 cm enhancement - Prior systemic and locoregional therapy, extrahepatic disease present Treated with Embrace® HES. - Complete Response per mRECIST at 30 days - Complete Response maintained at 90 days - No local tumor progression - No revascularization Conclusion: Sustained local disease control in an advanced-stage HCC patient with limited therapeutic options. This case underscores the effectiveness of embolization in an advanced-stage HCC patient with limited therapeutic options, demonstrating sustained local disease control despite prior systemic therapy, bland embolization, and extrahepatic disease View the full case: https://lnkd.in/giS6Anjz #EmbraceHES #Instylla #InterventionalRadiology #Embolization #IR #InterventionalOncology #HCC

The HoverMatt® PROS™ (Patient Repositioning Off-Loading System) portfolio of air and non-air breathable, wipeable matts are used to safely reposition (including boosting and turning), transfer, and prone patients to reduce patient and caregiver injuries. Link feature reduces boosting frequency and device migration and promotes caregiver safety by reducing pull force by 90%.

With ICH E6(R3) emphasizing data quality, traceability, and risk-based approaches, systems integration is more critical than ever in clinical trails. APIs power these integrations — but do you know when and why to use them? Learn the essentials in 3 fun levels with our interactive API game https://lnkd.in/eF8r5ygX.

Este 1 de octubre estaré presente en el Summit País Digital, compartiendo la visión de InterSystems Chile sobre cómo la innovación puede transformar la atención médica. 📍16:35 hrs. | el Dr. Alfredo Almerares, Clinical Executive Manager de InterSystems, presentará la demo “Superar las limitaciones de los RCE para acelerar la digitalización de la atención médica”. Mostraremos cómo una historia clínica electrónica mejorada con inteligencia artificial generativa puede automatizar tareas, entregar información en tiempo real y apoyar la toma de decisiones en el punto de atención. 📍17:00 hrs. | Participaré en el panel “De la Estrategia a la Acción: Desafíos y Estrategias para la Salud Digital en Chile”, donde profundizaremos en cómo pasar de la visión a la acción, abordando el rol de la inteligencia artificial generativa y otras innovaciones. Estaré junto a los responsables que hoy lideran la ejecución de la transformación digital en salud en nuestro país. Junto a: • Macarena Chait Diaz, MSc. Dr., Subgerenta de Informática Clínica, Achs • Dra. May Chomali, Directora Ejecutiva, CENS - Centro Nacional en Sistemas de Información en Salud • Dr. Hernán Carrillo Bestagno, Presidente Comité SIDRA • Francisco Fukuda, Director de Informática, REDSALUD Los invito a seguirnos y a ser parte de esta conversación inscribiendose en el siguiente link: https://lnkd.in/ePfjvhbR Fundación País Digital #SaludDigital #InterSystems #SummitPaísDigital

From day one, Inspiren has been committed to reimagining senior living through technology that drives outcomes that matter. What does this mean for operators, residents, and families? ✅ Safer communities with proactive fall prevention and proven results ✅ Real-time insights and support ✅ Residents experiencing better outcomes and longer stays This is just the beginning — together, we’re building the future of senior living.

Have you heard about our NEW product? Check out our website to shop an assortment of pill boxes for strip pouch packaging today. ✨ https://zurl.co/ZENUD

Would you let a urologist read your ECG? In this excerpt from Decoded: The Future of Health with Dr. Vinod Gauba MD and Alex Kummerman, our CEO, Dr. Nicole Sirotin recounts a moment that sparked a bold realization: the world needs real longevity doctors - those who understand the body as a complete system, not just a single organ. As longevity science evolves, so must the people we trust to guide it. . . . #GlobalHealthcare #longevity #healthandwellness #healthcare #healthylongevity #precisionmedicine #preventativehealth #preventativehealthcare #preventativemedicine #preventivemedicine #preventivehealth #healthylifestyle #preventivehealthcare #InstituteForHealthierLiving #IHLAD #IHLAbuDhabi #medicalresearch #scientificresearch #TraditionalMedicine #medicine #podcast #medicalpodcast

Looking for a safe way to reduce expenditures and nurse turnover? With over 750,000 calls triaged annually by experienced licensees, our approach scales while safeguarding PHI, cutting internal triage costs, and improving clinician satisfaction. IntellaTriage’s proprietary platform, IntellaHub, is HITRUST-certified, delivering on nurse-first triage with the industry’s top cybersecurity standard. Build a triage system that’s safe, scalable, and smart. Start with a strategy call.

En el Hospital del Trabajador Achs Salud, cada trayectoria refleja el compromiso de quienes dedican su vida a cuidar. 💙 El doctor Juan Pedro Bergeret Valladares lleva 12 años siendo parte de nuestro equipo de Traumatología. Para él, trabajar aquí ha sido cumplir un sueño: aplicar tecnología de vanguardia y las mejores prácticas médicas para lograr que cada paciente se recupere lo antes posible. Su mayor orgullo es ver cómo, gracias a una atención de calidad, las y los pacientes pueden volver a su vida laboral y familiar con seguridad y confianza. #Trayectoria #HospitalDelTrabajador #AchsSalud

Smarter, Faster, Safer: Precision Stevedores’ Workplace Drug Testing Upgrade. Precision Stevedores has replaced traditional urine and saliva tests with Intelligent Fingerprinting’s non-invasive, rapid drug testing solution. The result? Reduced downtime, faster testing, and improved employee experience.

Focused ultrasound offers eligible patients tremor relief – without incisions, implants, hospital stays or extended recovery times. See how you can be a part of helping patients regain control and reclaim their independence.

Join the movement towards incisionless therapy for essential tremor. Focused ultrasound is a safe and effective treatment, with minimal risks. Download the clinical summary to see the results.

#MiYOSMART. Les enfants inventent leur monde quand ils jouent, lisent ou découvrent de nouvelles passions. Plus leur vision est claire, plus leurs rêves sont audacieux. Le verre MiYOSMART est une solution innovante et probante spécialement conçue pour les enfants et jeunes myopes*. Soutenu par des études robustes prouvant son efficacité pour freiner l’évolution de la myopie infantile avec des résultats maintenus pendant plus de 8 ans*, MiYOSMART accompagne l’enfant aujourd’hui pour une meilleure vision demain. Ouvrez leur monde : découvrez MiYOSMART *Sur décision de l’ophtalmologiste *AVIS DE NON RESPONSABILITE : Leung et al. Comparaison de la progression de la myopie chez des individus portant des verres de lunettes à segments multiples incorporant du défocus (DIMS) pendant huit ans versus des durées plus courtes. Résumé présenté lors du congrès ARVO 2025.

For Dr. Abhay Sharma, MD, multiple factors excite him about the Inspire V™ system, specifically the simplified procedure. This includes a new integrated respiratory sensor, which eliminates the need to place a separate sensing lead. Ready to learn more about contracting the Inspire V system? Reach out to your Inspire therapy sales representative. Rx Only. Individual results may vary. View important safety information at inspiresleep.com/safety

Patients aren’t the only ones excited about the Inspire V™ system. Dr. Maria V. Suurna, MD, FACS & U.S. President of International Surgical Sleep Society shares why she’s been looking forward to having the Inspire V system as an option. To learn more about contracting the Inspire V system, connect with your Inspire® therapy sales representative. Rx Only. Individual results may vary. View important safety information at inspiresleep.com/safety #SleepProvider #ENT #Doctor #Sleep #Inspiretherapy

🧼 35 años cuidando lo que no siempre se ve, pero que lo cambia todo. Héctor Rivera forma parte del equipo que garantiza que cada espacio, cada herramienta y cada equipo médico del Hospital del Trabajador Achs Salud estén impecables y seguros para pacientes y profesionales. Su labor, silenciosa pero esencial, ha sido parte de nuestra historia por más de tres décadas. Porque cuidar la salud también comienza con un entorno limpio, seguro y confiable. 🩺 Gracias, Héctor, por 35 años de compromiso y excelencia. #CuidarTuBienestarEsNuestroSello #HospitalDelTrabajador #AchsSalud

When the efficacy of MIGS plateaus, higher-risk bleb-forming procedures have historically been the only remaining option. WHAT IF YOU COULD: • Delay the need for a bleb-forming procedure? • Surgically access a complementary, natural outflow path? • Add another surgical intervention to your toolkit? NOW, YOU CAN. Unlock a new surgical pathway to enhance natural outflow — with AlloFlo™ Uveo Dual Bio-Spacers and the Allosert™ Uveo Delivery Platform.